Journal of Chemical Information and Modeling · 2012 · 21 citations · 19 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryPharmacophore ModelingLigand BindingMolecular DockingPharmacophore Hypothesis GenerationPharmacophore ScreeningReceptor PharmacologyStructure-based Pharmacophore ModelingAromatic Ring FeaturesHydrogen Bond Acceptor FeaturesHydrophobic DescriptorsPharmacophore Hypothesis ConstructionPharmacophore Hypothesis ValidationPharmacophore Model ConstructionStructure-based Ligand DesignStructure-based Pharmacophore Design
The present study describes application of computational approaches to identify a validated and reliable 3D QSAR pharmacophore model for the CCK-2R antagonism through integrated ligand and structure based studies using anthranilic sulfonamide and 1,3,4-benzotriazepine based CCK-2R antagonists. The best hypothesis consisted five features viz. two aliphatic hydrophobic, one aromatic hydrophobic, one H-bond acceptor, and one ring aromatic feature with an excellent correlation for 34 training set (r²(training) = 0.83) and 58 test set compounds (r²(test) = 0.74). This model was validated through F-test and docking studies at the active site of the plausible CCK-2R where the 99% significance and well corroboration with the pharmacophore model respectively describes the model's reliability. The model also predicts well to other known clinically effective CCK-2R antagonists. Therefore, the developed model may useful in finding new scaffolds that may aid in design and develop new chemical entities (NCEs) as potent CCK-2R antagonists before their synthesis.
19
Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors.
Jean Claude Reubi, Jean‐Claude Schaer, Beatrice Waser · PubMed · 1997 · 352 citations
Medicine, Oncology, Pharmacology +13
Peter C. Konturek, Agnieszka Nikiforuk, Joanna Kania et al. · Digestive Diseases and Sciences · 2004 · 97 citations